Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Why Drugs That Eat Our Hunger Will Not Change Much

Mint Kolkata

|

July 28, 2025

They Won't Stop People From Eating Because Most Eat For Entertainment And Not To Satisfy Hunger

- MANU JOSEPH

Two drugs are generating the sort of cultural excitement that only Viagra once did. Like Viagra, their effects are visible, and often not attributed to the medicine. Semaglutide and Tirzepatide, known by their brand names Ozempic and Mounjaro, were designed to treat diabetes. But as often happens with iconic drugs, their fame lies in what they do on the side. They reduce appetite. So, people eat less and lose weight. Doctors are taking these drugs too, which is a good sign. Not that they are paragons of health, but they know how patients respond to the drugs and so it suggests they consider them safe. Meanwhile, society is bracing for a behavioral revolution. A certain leanness—a non-muscular kind in middle-aged people that I already associate with these drugs—might become another motif of wealth. At the moment, the drugs are for the affluent, but that can change over time. There is even a view that once these drugs go off patent and generics flood the market, they may hurt the restaurant business.

I doubt that. I think their impact will be modest. People do not eat because they're hungry, especially the rich. Even most of the poor no longer eat out of necessity alone. Nobody eats maida noodles and biryani out of hunger. For most people, eating is a form of entertainment. Even a source of happiness. Many people can bear the period between meals because they know food is coming. Many keep eating through the day because people do a lot of what is fun. Also, food is the most legit drug addiction.

FLERE HISTORIER FRA Mint Kolkata

Mint Kolkata

Indian IT slashes spending on lobbying in the US

Indian IT slashes spending on lobbying in the US had incurred lobbying costs of $90,000 in 2022 as against $210,000 in 2020. It has not employed any lobbying services since 2022.

time to read

1 mins

November 29, 2025

Mint Kolkata

Apple’s 5th India store to open in Noida soon

Apple announced on Friday it will open its fifth retail store in India on 1 December in Noida's DLF Mall of India—marking its second store in the National Capital Region after Delhi, which opened in April 2023.

time to read

1 min

November 29, 2025

Mint Kolkata

Mint Kolkata

Inside Bengaluru's quiet recycling revolution

Stories from the alleys and gullies of India

time to read

4 mins

November 29, 2025

Mint Kolkata

Mint Kolkata

The beauty and sadness of living in the hills

In ‘Called by the Hills’, her first book-length non-fiction work, Anuradha Roy pays a literary and painterly tribute to her home in the Himalayas

time to read

5 mins

November 29, 2025

Mint Kolkata

Fiscal deficit widens on higher capex, lower tax

India’s fiscal deficit for the April-October period rose on higher capital expenditure and lower net tax revenue.

time to read

1 min

November 29, 2025

Mint Kolkata

Mint Kolkata

Inside Bengaluru’s quiet recycling revolution

Stories from the alleys and gullies of India

time to read

5 mins

November 29, 2025

Mint Kolkata

Mint Kolkata

'The Family Man' S3: Agent down

The new season of the popular spy thriller series starring Manoj Bajpayee feels like a hedged bet

time to read

4 mins

November 29, 2025

Mint Kolkata

Fiscal deficit up on capex, lower tax

during the period, or 55.1% of the annual estimate for FY26, compared to %4.67 trillion or 42% ofthe annual estimate during the year-ago period.

time to read

1 min

November 29, 2025

Mint Kolkata

Equity treatment for Reits from 1 Jan

From 1 January 2026, any money put into Reits (real estate investment funds) by mutual funds and specialized investment funds (SIFs) will be treated as equity-linked investments.

time to read

1 min

November 29, 2025

Mint Kolkata

Mint Kolkata

Former DBS CEO is Temasek India’s new non-exec chair

Piyush Gupta, the former chief executive of DBS Group, has joined Singaporean state-owned multinational investment firm Temasek as India chairman, albeit in a non-executive role, and will work with Ravi Lambah, head of India and strategic initiatives, the firm said, He will join on 1 December.

time to read

1 mins

November 29, 2025

Listen

Translate

Share

-
+

Change font size